Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| R35CA197706 | Cancer Gene Discovery to Identify Targetable Targets | 3 | 2021 |
| P30MH062261 | Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center | 2 | 2021 |
| R00HL138268 | Molecular link between MCU and Mrs2p channels for mitochondrial ion homeostasis and energy metabolism | 2 | 2021 |
| R01AG033605 | Ligand-independent signaling of estrogen receptor beta and the aging brain | 2 | 2021 |
| R01AG056533 | Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease | 2 | 2021 |
| R01AI129788 | Epigenetic Mechanisms of T Cell Dysregulation in PTSD | 2 | 2021 |
| R01CA206069 | Development of Targeted Nanotechnology Platform for Pancreatic Cancer | 2 | 2021 |
| R01CA210192 | Targeted Nanotherapy for Pancreatic Cancer | 2 | 2021 |
| R01DK065073 | Inflammatory Gene Regulation in Diabetic Conditions | 2 | 2021 |
| R01ES017543 | Role of SMOC2 in Kidney Fibrosis | 2 | 2021 |
| R01LM012535 | Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease | 2 | 2021 |
| R01MH067234 | Effects Of Environmental Challenges On Genetically Modified Interneuronal Subpopulations | 2 | 2021 |
| R01MH094524 | Mining the Genomewide Scan: Genetic Profiles of Structural Loss in Schizophrenia | 2 | 2021 |
| R01NS105473 | Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease | 2 | 2021 |
| R21DA051798 | Cocaine upregulates mitochondria-derived vesicular pathway for selective removal of oxidized cargo | 2 | 2021 |
| U01MH115484 | Transgenerational Effects of Maternal Stressors: Investigating the Role of Infant Gene Expression | 2 | 2021 |
| ZIAMH002882 | Characterizing the Function of miRNAs in Neural Development, Synaptic Plasticity and Schizophrenia. | 2 | 2021 |
| F99NS115341 | miRNA Control of Synaptic Stability and Structural Plasticity | 1 | 2021 |
| I01BX003420 | Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance | 1 | 2021 |
| K23DK109134 | Mesenchymal stem cell senescence in diabetic nephropathy | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=25